ReviewMolecular biology reports2026
A review of animal models of vascular dementia.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular dementia (VD) is characterized by the presence of cerebrovascular lesions, specifically hemorrhagic or ischemic lesions within the brain parenchyma, with ischemic lesions being more prevalent. The resultant progressive decline in cognitive abilities and memory poses a significant challenge to public health and quality of life. Consequently, a growing number of researchers have focused on exploring the pathogenesis, prevention, and treatment strategies for VD. The establishment of suitable animal models for investigating the underlying mechanisms of VD treatment and assessing therapeutic efficacy has emerged as a focal point in this area of research. This review systematically compares the construction methods, pathological features, and behavioral phenotypes of classical and modified VD animal models, while analyzing their respective advantages and limitations. Key obstacles to clinical translation presented by the existing models are highlighted, including species differences, behavioral confounding factors, and issues related to methodological reproducibility. Furthermore, this article offers a reference framework for model selection based on various research objectives, aimed at enhancing the translational value of preclinical VD investigations.
Indexed as
Identifiers
42530688What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.